Fabrice Cognasse/LinkedIn
Feb 28, 2026, 14:43
Fabrice Cognasse: Honored to Contribute to New Reference Work on Platelets in Disease
Fabrice Cognasse, Director of Research – Scientific Director at The EFS in Auvergne-Rhône-Alpes and INSERM, shared a post on LinkedIn:
“There are expectations that make the finish even tastier.
Today, it is: ‘Platelets in Disease: Thrombotic Disorders and Disorders not Involving Hemorrhage or Thrombosis’ edited by Paolo Gresele, López J.A., Angiolillo D.J., and Page C.P. is finally in my hands.
A big thank you to the publishers for their trust and their invitation to contribute to this reference work!
‘The Inflammatory Role of the Platelets in Blood Transfusion’
Hind Hamzeh-Cognasse and Fabrice Cognasse.”
Other posts featuring Fabrice Cognasse on Hemostasis today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS